Detection	detection	O	O
of	of	O	O
abnormal	abnormal	O	O
cardiac	cardiac	O	O
adrenergic	adrenergic	B_chemicals	O
neuron	neuron	I_chemicals	O
activity	activity	O	O
in	in	O	O
adriamycin-induced	adriamycin-induced	O	O
cardiomyopathy	cardiomyopathy	O	S_disease
with	with	O	O
iodine-125-metaiodobenzylguanidine	iodine-125-metaiodobenzylguanidine	O	O
.	.	O	O

Radiolabeled	radiolabeled	O	O
metaiodobenzylguanidine	metaiodobenzylguanidine	O	O
(	(	O	O
MIBG	mibg	S_chemicals	O
)	)	O	O
,	,	O	O
an	an	O	O
analog	analog	S_chemicals	O
of	of	O	O
norepinephrine	norepinephrine	S_chemicals	O
(	(	O	O
NE	ne	O	O
)	)	O	O
,	,	O	O
serves	serves	O	O
as	as	O	O
an	an	O	O
index	index	O	O
of	of	O	O
adrenergic	adrenergic	B_chemicals	O
neuron	neuron	I_chemicals	O
integrity	integrity	O	O
and	and	O	O
function	function	O	O
.	.	O	O

Using	using	O	O
a	a	O	O
rat	rat	O	O
model	model	O	O
of	of	O	O
adriamycin-induced	adriamycin-induced	O	O
cardiomyopathy	cardiomyopathy	O	S_disease
,	,	O	O
we	we	O	O
tested	tested	O	O
the	the	O	O
hypothesis	hypothesis	O	O
that	that	O	O
abnormal	abnormal	O	O
cardiac	cardiac	O	O
adrenergic	adrenergic	B_chemicals	O
neuron	neuron	I_chemicals	O
activity	activity	O	O
may	may	O	O
appear	appear	O	O
and	and	O	O
be	be	O	O
exacerbated	exacerbated	O	O
dose-dependently	dose-dependently	O	O
in	in	O	O
adriamycin	adriamycin	O	O
cardiomyopathy	cardiomyopathy	O	S_disease
.	.	O	O

The	the	O	O
degree	degree	O	O
of	of	O	O
vacuolar	vacuolar	S_chemicals	O
degeneration	degeneration	O	O
of	of	O	O
myocardial	myocardial	O	O
cells	cells	O	O
was	was	O	O
analyzed	analyzed	O	O
in	in	O	O
relation	relation	O	O
to	to	O	O
the	the	O	O
duration	duration	O	O
of	of	O	O
adriamycin	adriamycin	O	O
treatment	treatment	O	O
(	(	B_chemicals	O
2	2	I_chemicals	O
mg/kg	mg/kg	O	O
,	,	O	O
once	once	O	O
a	a	O	O
week	week	O	O
)	)	O	O
.	.	O	O

There	there	O	O
were	were	O	O
no	no	O	O
abnormalities	abnormalities	O	O
or	or	O	O
only	only	O	O
isolated	isolated	O	O
degeneration	degeneration	O	O
in	in	O	O
the	the	O	O
1-	1-	O	O
or	or	O	O
2-wk	2-wk	O	O
treatment	treatment	O	O
groups	groups	O	O
,	,	O	O
isolated	isolated	O	O
or	or	O	O
scattered	scattered	O	O
degeneration	degeneration	O	O
in	in	O	O
half	half	O	O
of	of	O	O
the	the	O	O
3-wk	3-wk	O	O
group	group	O	O
,	,	O	O
frequent	frequent	O	O
scattered	scattered	O	O
degeneration	degeneration	O	O
in	in	O	O
the	the	O	O
4-wk	4-wk	O	O
group	group	O	O
,	,	O	O
scattered	scattered	O	O
or	or	O	O
focal	focal	O	O
degeneration	degeneration	O	O
in	in	O	O
the	the	O	O
5-wk	5-wk	O	O
group	group	O	O
,	,	O	O
and	and	O	O
extensive	extensive	O	O
degeneration	degeneration	O	O
in	in	O	O
the	the	O	O
8-wk	8-wk	O	O
group	group	O	O
.	.	O	O

Myocardial	myocardial	O	O
accumulation	accumulation	O	O
of	of	O	O
[125I]MIBG	[125i]mibg	O	O
4	4	O	O
hr	hr	O	O
after	after	O	O
intravenous	intravenous	O	O
injection	injection	O	O
did	did	O	O
not	not	O	O
differ	differ	O	O
between	between	O	O
the	the	O	O
controls	controls	O	O
and	and	O	O
the	the	O	O
groups	groups	O	O
treated	treated	O	O
3	3	O	O
wk	wk	O	O
or	or	O	O
less	less	O	O
.	.	O	O

However	however	O	O
,	,	O	O
the	the	O	O
4-wk	4-wk	O	O
group	group	O	O
had	had	O	O
a	a	O	O
slightly	slightly	O	O
lower	lower	O	O
accumulation	accumulation	O	O
in	in	O	O
the	the	O	O
right	right	O	B_disease
ventricular	ventricular	O	I_disease
wall	wall	O	O
(	(	O	O
82	82	O	O
%	%	O	O
of	of	O	O
the	the	O	O
control	control	O	O
)	)	O	O
and	and	O	O
significantly	significantly	O	O
lower	lower	O	O
accumulation	accumulation	O	O
in	in	O	O
the	the	O	O
left	left	O	B_disease
ventricular	ventricular	O	I_disease
wall	wall	O	O
(	(	O	O
about	about	O	O
66	66	O	O
%	%	O	O
of	of	O	O
the	the	O	O
control	control	O	O
:	:	O	O
p	p	O	O
less	less	O	O
than	than	O	O
0.05	0.05	O	O
)	)	O	O
.	.	O	O

In	in	O	O
the	the	O	O
5-wk	5-wk	O	O
group	group	O	O
,	,	O	O
MIBG	mibg	S_chemicals	O
accumulation	accumulation	O	O
in	in	O	O
the	the	O	O
right	right	O	O
and	and	O	O
left	left	O	B_disease
ventricular	ventricular	O	I_disease
wall	wall	O	O
was	was	O	O
35	35	O	O
%	%	O	O
and	and	O	O
27	27	O	O
%	%	O	O
of	of	O	O
that	that	O	O
in	in	O	O
controls	controls	O	O
,	,	O	O
respectively	respectively	O	O
(	(	O	O
p	p	O	O
less	less	O	O
than	than	O	O
0.001	0.001	O	O
)	)	O	O
.	.	O	O

In	in	O	O
the	the	O	O
8-wk	8-wk	O	O
group	group	O	O
,	,	O	O
MIBG	mibg	S_chemicals	O
accumulation	accumulation	O	O
in	in	O	O
the	the	O	O
right	right	O	O
and	and	O	O
left	left	O	B_disease
ventricular	ventricular	O	I_disease
wall	wall	O	O
was	was	O	O
18	18	O	O
%	%	O	O
and	and	O	O
14	14	O	O
%	%	O	O
of	of	O	O
that	that	O	O
in	in	O	O
controls	controls	O	O
,	,	O	O
respectively	respectively	O	O
(	(	O	O
p	p	O	O
less	less	O	O
than	than	O	O
0.001	0.001	O	O
)	)	O	O
.	.	O	O

Thus	thus	O	O
,	,	O	O
MIBG	mibg	S_chemicals	O
accumulation	accumulation	O	O
in	in	O	O
the	the	O	O
myocardium	myocardium	O	O
decreased	decreased	O	O
in	in	O	O
an	an	O	O
adriamycin	adriamycin	O	O
dose-dependent	dose-dependent	O	O
manner	manner	O	O
.	.	O	O

The	the	O	O
appearance	appearance	O	O
of	of	O	O
impaired	impaired	O	O
cardiac	cardiac	O	O
adrenergic	adrenergic	B_chemicals	O
neuron	neuron	I_chemicals	O
activity	activity	O	O
in	in	O	O
the	the	O	O
presence	presence	O	O
of	of	O	O
slight	slight	O	O
myocardial	myocardial	O	O
impairment	impairment	O	O
(	(	O	O
scattered	scattered	O	O
or	or	O	O
focal	focal	O	O
vacuolar	vacuolar	S_chemicals	O
degeneration	degeneration	O	O
)	)	O	O
indicates	indicates	O	O
that	that	O	O
MIBG	mibg	S_chemicals	O
scintigraphy	scintigraphy	O	O
may	may	O	O
be	be	O	O
a	a	O	O
useful	useful	O	O
method	method	O	O
for	for	O	O
detection	detection	O	O
of	of	O	O
adriamycin-induced	adriamycin-induced	O	O
cardiomyopathy	cardiomyopathy	O	S_disease
.	.	O	O

